Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Gianluca Gaïdano, Agostino Cortelezzi et al.|Blood|2015Cited by 215
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathSara Serra, Silvia Deaglio, Alberto L. Horenstein et al.|Blood|2011Cited by 138
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironmentSara Serra, Silvia Deaglio, Tiziana Vaisitti et al.|Blood Advances|2016Cited by 57
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemiaCandida Vitale, Marta Coscia|Scientific Reports|2023Cited by 5
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐upPaola Ghione, Simone Ferrero, Elisa Genuardi et al.|British Journal of Haematology|2017Cited by 1